Advertisement
Canada markets open in 6 hours 47 minutes

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7333
    +0.0010 (+0.13%)
     

  • CRUDE OIL

    84.01
    +0.44 (+0.53%)
     

  • Bitcoin CAD

    87,757.38
    +132.25 (+0.15%)
     

  • CMC Crypto 200

    1,391.37
    -5.17 (-0.37%)
     

  • GOLD FUTURES

    2,350.30
    +7.80 (+0.33%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,774.75
    +207.25 (+1.18%)
     

  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6828
    +0.0007 (+0.10%)
     

Five Star Equities Issues New Research Reports on EW, COV, SYY and YRCW

ACCESSWIRE

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.

Edwards Lifesciences Corp. (NYSE:EW - News) shares declined 5.37 percent to close at $62.73 a share Monday. The stock traded between $61.91 and $64.33 on volume 5.91 million shares traded. The company announced that total global THV sales for 2014 are expected to be between $700.0 million and $820.0 million. Shares of Edwards Lifesciences have fallen approximately 30.0 percent year-to-date.

Get more information on Edwards Lifesciences free access to the in-depth equity report at:
www.FiveStarEquities.com/EW

Covidien plc (NYSE:COV - News) shares increased 0.09 percent to close at $68.13 a share Monday. The stock traded between $67.88 and $68.78 on volume 2.25 million shares traded. The company announced that it has agreed to acquire Given Imaging Ltd. for approximately $860.0 million. Shares of Covidien have gained approximately 18.0 percent year-to-date.

ADVERTISEMENT

Get more information on Covidien and free access to the in-depth equity report at:
www.FiveStarEquities.com/COV

SYSCO Corporation (NYSE:SYY - News) shares spiked 9.65 percent to close at $37.62 a share Monday. The stock traded between $36.69 and $43.40 on volume 71.68 million shares traded. The company announced that it has agreed to acquire the equity of US Foods for approximately $3.5 billion. Shares of SYSCO have gained approximately 18.0 percent year-to-date.

Get more information on SYSCO and free access to the in-depth equity report at:
www.FiveStarEquities.com/SYY

YRC Worldwide, Inc. (NASDAQ:YRCW - News) shares surged 18.34 percent to close at $10.00 a share Monday. The stock traded between $9.05 and $10.50 on volume of 3.21 million shares traded. The company’s union has agreed to vote on extending an agreement that would help refinance almost $1 billion of debt. Shares of YRC Worldwide have gained approximately 45.0 percent year-to-date.

Get more information on YRC Worldwide and free access to the in-depth equity report at:
www.FiveStarEquities.com/YRCW

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Five Star Equities
info@fivestarequities.com